Bone Biologics (BBLG) Competitors $2.73 -0.07 (-2.50%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.73 0.00 (0.00%) As of 08/1/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock BBLG vs. STSS, QNRX, NDRA, CHEK, HSCS, BLAC, AMIX, VERO, XAGE, and GCTKShould you be buying Bone Biologics stock or one of its competitors? The main competitors of Bone Biologics include Sharps Technology (STSS), Quoin Pharmaceuticals (QNRX), ENDRA Life Sciences (NDRA), Check-Cap (CHEK), HeartSciences (HSCS), Bellevue Life Sciences Acquisition (BLAC), Autonomix Medical (AMIX), Venus Concept (VERO), Longevity Health (XAGE), and GlucoTrack (GCTK). These companies are all part of the "medical equipment" industry. Bone Biologics vs. Its Competitors Sharps Technology Quoin Pharmaceuticals ENDRA Life Sciences Check-Cap HeartSciences Bellevue Life Sciences Acquisition Autonomix Medical Venus Concept Longevity Health GlucoTrack Bone Biologics (NASDAQ:BBLG) and Sharps Technology (NASDAQ:STSS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability. Which has better earnings & valuation, BBLG or STSS? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBone BiologicsN/AN/A-$4.11MN/AN/ASharps TechnologyN/AN/A-$9.30M-$1.88 thousand0.00 Does the media prefer BBLG or STSS? In the previous week, Sharps Technology had 1 more articles in the media than Bone Biologics. MarketBeat recorded 1 mentions for Sharps Technology and 0 mentions for Bone Biologics. Bone Biologics' average media sentiment score of 0.00 beat Sharps Technology's score of -0.71 indicating that Bone Biologics is being referred to more favorably in the media. Company Overall Sentiment Bone Biologics Neutral Sharps Technology Negative Which has more risk & volatility, BBLG or STSS? Bone Biologics has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, Sharps Technology has a beta of 2.15, indicating that its stock price is 115% more volatile than the S&P 500. Do insiders & institutionals believe in BBLG or STSS? 34.3% of Bone Biologics shares are owned by institutional investors. Comparatively, 17.2% of Sharps Technology shares are owned by institutional investors. 6.1% of Bone Biologics shares are owned by insiders. Comparatively, 1.5% of Sharps Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is BBLG or STSS more profitable? Sharps Technology's return on equity of -98.77% beat Bone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Bone BiologicsN/A -130.21% -119.39% Sharps Technology N/A -98.77%-53.85% SummaryBone Biologics and Sharps Technology tied by winning 4 of the 8 factors compared between the two stocks. Get Bone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBLG vs. The Competition Export to ExcelMetricBone BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.53M$3.00B$5.47B$9.53BDividend YieldN/A2.44%4.74%4.08%P/E RatioN/A17.6228.6723.80Price / SalesN/A269.12422.3188.12Price / CashN/A41.9535.4557.96Price / Book0.338.508.275.55Net Income-$4.11M-$55.06M$3.24B$259.03M7 Day Performance-9.60%-3.98%-3.63%-4.56%1 Month Performance-24.59%9.59%4.40%4.49%1 Year Performance-83.27%6.72%25.97%18.05% Bone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBLGBone Biologics0.7796 of 5 stars$2.73-2.5%N/A-83.3%$1.53MN/A0.002Upcoming EarningsAnalyst UpgradeSTSSSharps Technology0.8015 of 5 stars$5.64-6.5%N/AN/A$5.75MN/A0.003Positive NewsGap DownQNRXQuoin Pharmaceuticals1.6887 of 5 stars$8.09-0.9%N/A-67.0%$4.76MN/A-0.174News CoveragePositive NewsNDRAENDRA Life Sciences1.4186 of 5 stars$5.82-8.3%$50.00+759.1%-99.9%$4.37MN/A-0.0320Positive NewsShort Interest ↑Gap DownCHEKCheck-CapN/A$0.72-3.7%N/A-66.1%$4.21MN/A-0.2480Positive NewsHSCSHeartSciences2.2695 of 5 stars$3.55+0.3%$13.00+266.2%-21.6%$3.83MN/A-0.3810News CoverageUpcoming EarningsBLACBellevue Life Sciences AcquisitionN/A$0.94-3.7%N/A-93.6%$3.81MN/A0.00N/AGap UpHigh Trading VolumeAMIXAutonomix Medical3.1288 of 5 stars$1.27-3.1%$16.50+1,199.2%-93.3%$3.53MN/A-0.171Gap DownHigh Trading VolumeVEROVenus Concept1.294 of 5 stars$2.44-3.9%N/A-66.2%$3.48M$61.00M-0.03410Gap UpXAGELongevity HealthN/A$3.41-12.8%N/AN/A$3.41M$50K0.0014News CoverageGCTKGlucoTrack0.2534 of 5 stars$6.57-4.1%N/A-99.6%$3.27MN/A-0.125News CoveragePositive News Related Companies and Tools Related Companies STSS Alternatives QNRX Alternatives NDRA Alternatives CHEK Alternatives HSCS Alternatives BLAC Alternatives AMIX Alternatives VERO Alternatives XAGE Alternatives GCTK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBLG) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBLG Stock Alerts